Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking.

Campion CG, Zaoui K, Verissimo T, Cossette S, Matsuda H, Solban N, Hamet P, Tremblay J.

Cell Rep. 2018 Jul 17;24(3):670-684.e7. doi: 10.1016/j.celrep.2018.06.056.

2.

Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease.

Kiper POS, Saito H, Gori F, Unger S, Hesse E, Yamana K, Kiviranta R, Solban N, Liu J, Brommage R, Boduroglu K, Bonafé L, Campos-Xavier B, Dikoglu E, Eastell R, Gossiel F, Harshman K, Nishimura G, Girisha KM, Stevenson BJ, Takita H, Rivolta C, Superti-Furga A, Baron R.

N Engl J Med. 2016 Jun 30;374(26):2553-2562. doi: 10.1056/NEJMoa1509342.

3.

Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.

Wang X, Solban N, Khanna P, Callea M, Song J, Alsop DC, Pearsall RS, Atkins MB, Mier JW, Signoretti S, Alimzhanov M, Kumar R, Bhasin MK, Bhatt RS.

Oncotarget. 2016 Jul 5;7(27):41857-41869. doi: 10.18632/oncotarget.9621.

4.

A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.

Baud'huin M, Solban N, Cornwall-Brady M, Sako D, Kawamoto Y, Liharska K, Lath D, Bouxsein ML, Underwood KW, Ucran J, Kumar R, Pobre E, Grinberg A, Seehra J, Canalis E, Pearsall RS, Croucher PI.

Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12207-12. doi: 10.1073/pnas.1204929109. Epub 2012 Jul 3.

5.

Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

Celli JP, Solban N, Liang A, Pereira SP, Hasan T.

Lasers Surg Med. 2011 Sep;43(7):565-74. doi: 10.1002/lsm.21093.

6.

Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.

Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, Solban N, Sako D, Pearsall RS, Underwood KW, Seehra J, Kumar R, Grinberg AV.

J Biol Chem. 2011 Aug 26;286(34):30034-46. doi: 10.1074/jbc.M111.260133. Epub 2011 Jul 7.

7.

ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.

Mitchell D, Pobre EG, Mulivor AW, Grinberg AV, Castonguay R, Monnell TE, Solban N, Ucran JA, Pearsall RS, Underwood KW, Seehra J, Kumar R.

Mol Cancer Ther. 2010 Feb;9(2):379-88. doi: 10.1158/1535-7163.MCT-09-0650. Epub 2010 Feb 2.

8.

In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.

Chang SK, Rizvi I, Solban N, Hasan T.

Clin Cancer Res. 2008 Jul 1;14(13):4146-53. doi: 10.1158/1078-0432.CCR-07-4536.

9.

A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.

Kosharskyy B, Solban N, Chang SK, Rizvi I, Chang Y, Hasan T.

Cancer Res. 2006 Nov 15;66(22):10953-8.

10.

Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

Solban N, Selbo PK, Sinha AK, Chang SK, Hasan T.

Cancer Res. 2006 Jun 1;66(11):5633-40. Erratum in: Cancer Res. 2006 Jul 1;66(13):6894. Pål, Selbo K [corrected to Selbo, Pål K]; Alok, Sinha K [corrected to Sinha, Alok K]; Sung, Chang K [corrected to Chang, Sung K].

11.

Targeted photodynamic therapy.

Solban N, Rizvi I, Hasan T.

Lasers Surg Med. 2006 Jun;38(5):522-31. Review.

PMID:
16671102
12.

HCaRG increases renal cell migration by a TGF-alpha autocrine loop mechanism.

El Hader C, Tremblay S, Solban N, Gingras D, Béliveau R, Orlov SN, Hamet P, Tremblay J.

Am J Physiol Renal Physiol. 2005 Dec;289(6):F1273-80. Epub 2005 Jul 20.

13.

Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

Chen B, Pogue BW, Zhou X, O'Hara JA, Solban N, Demidenko E, Hoopes PJ, Hasan T.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):720-7.

14.

Targeted optical imaging and photodynamic therapy.

Solban N, Ortel B, Pogue B, Hasan T.

Ernst Schering Res Found Workshop. 2005;(49):229-58. Review. No abstract available.

PMID:
15524219
15.

In vivo flow cytometry: a new method for enumerating circulating cancer cells.

Georgakoudi I, Solban N, Novak J, Rice WL, Wei X, Hasan T, Lin CP.

Cancer Res. 2004 Aug 1;64(15):5044-7.

16.

HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest.

Devlin AM, Solban N, Tremblay S, Gutkowska J, Schürch W, Orlov SN, Lewanczuk R, Hamet P, Tremblay J.

Am J Physiol Renal Physiol. 2003 Apr;284(4):F753-62. Epub 2002 Dec 3.

17.

Chromosomal mapping of HCaRG, a novel hypertension-related, calcium-regulated gene.

Solban N, Dumas P, Gossard F, Sun Y, Pravenec M, Kren V, Lewanczuk R, Hamet P, Tremblay J.

Folia Biol (Praha). 2002;48(1):9-14.

PMID:
11871861
18.

HCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation.

Solban N, Jia HP, Richard S, Tremblay S, Devlin AM, Peng J, Gossard F, Guo DF, Morel G, Hamet P, Lewanczuk R, Tremblay J.

J Biol Chem. 2000 Oct 13;275(41):32234-43.

Supplemental Content

Loading ...
Support Center